Events Partner Content SMi's 10th Annual RNA Therapeutics Returns this February 201... RNA Therapeutics 2019
Partner Content Partner Content The 10th Annual RNA Therapeutics Returns to London this Feb! RNA Therapeutics
Partner Content Partner Content A Run Down of Keynote Sessions for Cell & Gene Therapy 2... Cell and Gene Therapy
Partner Content Partner Content Explore the latest developments in ATMPs at Cell & Gene ... Cell & Gene Therapy 2018
Partner Content Partner Content Attendee List Released for SMi’s 9th Annual RNA Therapeutics RNA Therapeutics
Partner Content Partner Content RNA Therapeutics conference will take place in just 4 weeks! 4 Weeks Until RNA Therapeutics
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.